Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00359515 · ClinicalTrials.gov registry record

Genetic Analysis of Oculocerebrorenal Syndrome of Lowe

A clinical trial, sponsored by National Human Genome Research Institute (NHGRI).

Completed
Registry status
120
Enrollment target

NCT00359515 is a clinical trial that has completed, run by National Human Genome Research Institute (NHGRI). The registered enrollment target is 120 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00359515 has completed, sponsored by National Human Genome Research Institute (NHGRI).

COMPLETED
Registry status
120 participants
Enrollment target

Study Summary

This study will investigate the genetic basis of oculocerebrorenal syndrome of Lowe (OCRL)-a rare X-linked disorder (carried by females and passed to males). Patients with OCRL have abnormal development of the eye lens, developmental delay, muscle weakness and kidney dysfunction. The study will examine DNA and cell samples obtained and archived from patients with OCRL enrolled in a previous protocol (HG008A) between 1996 and 1999. It will identify mutations in the OCRL1 gene responsible for OCRL in affected males and try to correlate them with specific biochemical or cellular activities (e.g., enzyme activity, protein stability, cellular localization and trafficking). When test results are available, the information will be communicated to the patients, their parents (if the patient is a minor) and their physicians, and families will receive genetic counseling.

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2001-02-17
Est. Completion 2009-02-03

What the Registry Record Tells You About NCT00359515

The ClinicalTrials.gov registry entry for NCT00359515 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Human Genome Research Institute (NHGRI), which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00359515 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00359515 about?

NCT00359515 is a clinical study titled "Genetic Analysis of Oculocerebrorenal Syndrome of Lowe". This study will investigate the genetic basis of oculocerebrorenal syndrome of Lowe (OCRL)-a rare X-linked disorder (carried by females and passed to males). Patients with OCRL have abnormal development of the eye lens, developmental delay, muscle weakness and kidney dysfunction. The study will exa...

What is the current status of trial NCT00359515?

This trial is currently completed. The enrollment target is 120 participants. The study started on 2001-02-17. Estimated completion is 2009-02-03.

Who is sponsoring clinical trial NCT00359515?

This trial is sponsored by National Human Genome Research Institute (NHGRI), which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.